Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancer Science|November 27, 2008
Interferon-alpha enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft modelsShigeto Kawai, Yumiko Azuma, Etsuko Fujii, et al.
The Journal of Toxicological Sciences|October 9, 2010
Cell proliferative activity in the kidney of young growing rat analyzed using flash and cumulative labeling with bromodeoxyuridineMasami Suzuki, Kaori Isobe, Etsuko Fujii, et al.
Scientific Reports|December 22, 2021
Generation of a lung squamous cell carcinoma three-dimensional culture model with keratinizing structuresShigeto Kawai, Kiyotaka Nakano, Keiichi Tamai, et al.
Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society|May 23, 2018
Advantages of evaluating γH2AX induction in non-clinical drug developmentShigeki Motoyama, Akira Takeiri, Kenji Tanaka, et al.
Laboratory Animals|June 10, 2009
Spontaneous thymic lymphomas in the non-obese diabetic/Shi-scid, IL-2R gamma (null) mouseChie Kato, Etsuko Fujii, Yu Jau Chen, et al.
Journal of Toxicologic Pathology|November 6, 2018
Difference in morphology and interactome profiles between orthotopic and subcutaneous gastric cancer xenograft modelsKiyotaka Nakano, Takashi Nishizawa, Daisuke Komura, et al.
Oncology Reports|September 6, 2019
In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation modelTakashi Nishizawa, Kiyotaka Nakano, Etsuko Fujii, et al.
Pathology International|September 20, 2008
Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouseEtsuko Fujii, Masami Suzuki, Koichi Matsubara, et al.
Journal of Toxicologic Pathology|January 25, 2013
Stimulation of adrenal chromaffin cell proliferation by hypercalcemia induced by intravenous infusion of calcium gluconate in ratsKaori Isobe, Tsuneo Ito, Shun-Ichiro Komatsu, et al.
Cancer Research Communications|February 2, 2026
CLDN6 Expression Plasticity in Ovarian Cancer: Insights into Therapeutic Optimization for CLDN6-Targeted ImmunotherapyNaoki Kimura, Kenji Taniguchi, Shinichi Onishi, et al.
Pageof 5